 Sarcoma
"Sarcoma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A connective tissue neoplasm formed by proliferation of mesodermal cells; it is usually highly malignant.
| Descriptor ID |
D012509
|
| MeSH Number(s) |
C04.557.450.795
|
| Concept/Terms |
Sarcoma- Sarcoma
- Sarcomas
- Sarcoma, Soft Tissue
- Sarcomas, Soft Tissue
- Soft Tissue Sarcoma
- Soft Tissue Sarcomas
Sarcoma, Epithelioid- Sarcoma, Epithelioid
- Epithelioid Sarcoma
- Epithelioid Sarcomas
- Sarcomas, Epithelioid
Sarcoma, Spindle Cell- Sarcoma, Spindle Cell
- Sarcomas, Spindle Cell
- Spindle Cell Sarcoma
- Spindle Cell Sarcomas
|
Below are MeSH descriptors whose meaning is more general than "Sarcoma".
Below are MeSH descriptors whose meaning is more specific than "Sarcoma".
This graph shows the total number of publications written about "Sarcoma" by people in this website by year, and whether "Sarcoma" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 | | 1998 | 1 | 0 | 1 | | 2000 | 0 | 1 | 1 | | 2002 | 1 | 0 | 1 | | 2003 | 2 | 0 | 2 | | 2007 | 1 | 0 | 1 | | 2008 | 2 | 0 | 2 | | 2009 | 3 | 0 | 3 | | 2010 | 2 | 0 | 2 | | 2011 | 2 | 0 | 2 | | 2012 | 1 | 0 | 1 | | 2013 | 7 | 0 | 7 | | 2014 | 3 | 0 | 3 | | 2015 | 6 | 2 | 8 | | 2016 | 8 | 0 | 8 | | 2017 | 6 | 1 | 7 | | 2018 | 18 | 0 | 18 | | 2019 | 7 | 0 | 7 | | 2020 | 8 | 0 | 8 | | 2021 | 12 | 0 | 12 | | 2022 | 8 | 0 | 8 | | 2023 | 11 | 0 | 11 | | 2024 | 12 | 2 | 14 | | 2025 | 9 | 0 | 9 | | 2026 | 4 | 1 | 5 |
To return to the timeline, click here.
Below are the most recent publications written about "Sarcoma" by people in Profiles.
-
Lammers ML, Sholevar CJ, Karimzadeh M, Razmara AM, Cruz SM, Purl MC, Liu NM, Bakke D, Plagens RN, Elliott A, Sheng MK, Dongen CV, Tran T, Trinh AT, Nielsen RN, Kotamraju T, Farley LE, Iranpur KR, Mukarrama T, Gronchi A, Riedel RF, Monjazeb AM, Thorpe SW, Darrow MA, Kim J, Murphy WJ, Judge SJ, Canter RJ. Intratumoral TIGIT blockade augments antitumor responses and bypasses increased functionality of peripheral TIGIT+ NK cells in mouse and human models of bone and soft tissue sarcoma. J Immunother Cancer. 2026 Jul 22; 14(7).
-
Romell J, Moro CF, Brodin B, Szekely L, Porovic E, Tsagkozis P, Sparrelid E, Björnstedt M, Hertz HM. X-ray histology on rapidly fixed fresh tumor tissue samples for fast resection margin assessment. Sci Rep. 2026 Jul 11; 16(1).
-
Furtado Neves PJ, Simioni A, Ishida AH, Kim SP, Gleisner AL, Mungo B, McCarter MD, Jacobs DL, Malgor EA, Malgor RD. Trends and Outcomes of Surgical Reconstruction of the IVC after Oncologic Resection. J Am Coll Surg. 2026 Jun 01; 242(6):1568-1578.
-
Callegaro D, Tinè G, Pasquali S, Stacchiotti S, Casali PG, Wunder JS, Ferguson PC, Griffin A, Strauss DC, Hayes AJ, Bonvalot S, Tzanis D, Bouhadiba T, Eckardt MA, Song JH, Raut CP, Gronchi A, Miceli R. Bayesian sequential learning for prognostication in extremity soft tissue sarcoma (BayeSarc): a retrospective, multicentre cohort study. Lancet Oncol. 2026 May; 27(5):637-648.
-
Kraguljac S, Seif H, Seif M, Whittles J, Najafali D, Oakes B, Pozin M, Yu JW, Hajjar F, Flores R, Lopez J. A Primer for Pediatric Plastic Surgeons on Pediatric Head and Neck Malignancies: Part I-Epidemiology and Overview of Common Pediatric Head and Neck Tumors. Ann Plast Surg. 2026 05 01; 96(5):435-443.
-
Chhabra A, Murphey MD, Rehman M, Chalian M, Subhawong T, Ahlawat S, Motamedi K, Wu JS, Amini B, Bajaj G, Samet J, Ramachandran S, Havranek M, Xi Y, Fanburg-Smith J, Choy E, Morris CD, Garner HW. Soft tissue reporting and data system (soft tissue-RADS): framework for radiologists specializing in imaging of musculoskeletal tumors and tumor-like lesions. Skeletal Radiol. 2026 Jun; 55(6):1227-1267.
-
von Mehren M, Kane JM, Armstrong SA, Balach T, Bishop AJ, Buehler D, Carr-Ascher J, Choy E, Cipriano C, Connolly M, Dann A, Davis EJ, Dry S, Eulo V, Ganjoo KN, Gonzalez RJ, De Viveiros PAH, Hitchcock YJ, Kim E, Lefler D, Liebner D, McCarter M, McGarry SV, Mesko NW, Meyer C, Motamedi K, Movva S, Pappo AS, Pollack SM, Poppe M, Riedel RF, Robinson S, Schuetze SM, Sicklick JK, Tseng WW, Weiss MC, Zimel M, Hang LE, Bergman MA, Diwan Z. NCCN Guidelines® Insights: Soft Tissue Sarcoma, Version 1.2025. J Natl Compr Canc Netw. 2025 Dec; 23(12):498-506.
-
Eckardt MA, Siena NM, Copeland AR, McCaw TR, Shehata MS, Lofftus SY, Graham DS, Dao HB, Singh AS, Chmielowski B, Federman N, Kadera BE, Kalbasi A, Bernthal NM, Eilber FR, Dry SM, Nelson SD, Eilber FC, Crompton JG. Dedicated review of sarcoma pathology is necessary for corroborative diagnosis in nearly one half of referred patients. Surgery. 2025 Dec; 188:109610.
-
Siontis BL, Rice JD, Schuetze SM, Rottmann D, Angeles CV, Fox AK, Zyczynski LE, Hayek S, Robinson SI, Okuno SH, Ho TP, Chugh R. A Phase II Multicenter Trial of Trabectedin in Combination with Olaparib in Patients with Advanced Unresectable or Metastatic Sarcoma. Clin Cancer Res. 2025 Jul 15; 31(14):2919-2925.
-
Wilky BA, Julian KA, Maleddu A, Mailhot AC, Cartwright CR, Gao D, Moreno Tellez C, Kemp LE, Therrien NR, Chaudhry SS, Rytlewski JD, Brockman QR, Davila E, Elias AD. A Single-Arm Phase 2 Trial of Doxorubicin Plus Zalifrelimab (Anti-CTLA-4 Antibody) and Balstilimab (Anti-PD-1 Antibody) in Advanced/Metastatic Soft Tissue Sarcomas. Clin Cancer Res. 2025 Jul 15; 31(14):2945-2956.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|